Table 2 Gastrointestinal pathogen PCR panel and Clostridium difficile test outcomes in patients with and without vancomycin resistant Enterococcus colonization
From: Gut colonization with vancomycin-resistant Enterococcus and risk for subsequent enteric infection
Variable | Total (n = 761) | No VRE (n = 630) | VRE (n = 131) | p value |
|---|---|---|---|---|
GI PCR tests | 761 | 630 (82.8%) | 131 (17.2%) | |
Positive | 126 (17%) | 114 (18.1%) | 12 (9.2%) | 0.01 |
Tests with more than one pathogen | 34 (4.5%) | 32 (5.1%) | 2 (1.5%) | 0.07 |
Place of test | ||||
Emergency department | 98 (12.9%) | 81 (12.9%) | 17 (13%) | |
Endoscopy | 7 (0.9%) | 7 (1.1%) | 0 | |
Inpatient | 452 (60%) | 373 (59.2%) | 79 (60%) | |
Outpatient | 204 (27%) | 169 (26.8%) | 35 (27%) | 0.69 |
Days from VRE test to GI PCR (median, IQR) | 42 (5–463) | 37 (5–495) | 51 (6–479) | 0.25 |
Test obtained during initial hospital stay | 369 (48%) | 312 (49.5%) | 57 (43.5%) | 0.21 |
C. difficile PCR tests | 716 | 586 (81.8%) | 130 (18.2%) | |
Positive | 81 (11%) | 61 (10.4%) | 20 (15%) | 0.11 |
Place of test | ||||
Inpatient | 635 (100%) | 586 (100%) | 130 (100%) | – |
Days from VRE test to CDI testing (median, IQR) | 23 (4–370) | 18 (4–351) | 41 (5–503) | 0.13 |
Test obtained during initial hospital stay | 439 (61%) | 364 (62%) | 75 (58%) | 0.11 |